Search Browse Earnings

BIOVIE INC. — SlamSEC

BIOVIE INC.

Nasdaq:BIVINasdaq:BIVIW

Pharmaceutical Preparations·CARSON CITY, NV

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$32.1M

FY 2025

EPS (Diluted)

-$73.05

FY 2025

Stock Price

$1.43

+1.4%

2026-03-16

52W Range

$1.06 – $13.20

P/E Ratio

-0.0x

Market Cap

$10.8M

Cash

$23.8M

FY 2025

Total Debt

$5.8M

FY 2021

Net Cash

$18.1M

FY 2021

Enterprise Value

-$7.3M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Do Cuong V

CFO

Kim Joanne Wendy